WHO
REGULATORY UPDATE
41st Invitation of Active Pharmaceutical Ingredients (APIs)
Published: 7/21/2026Detected: 5/26/2026
Summary preview
Adds three new active pharmaceutical ingredients (APIs)—buprenorphine (hydrochloride), methadone (hydrochloride), and naloxone (hydrochloride)—for products used in the treatment of substance use disorders.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountpsychiatry
manufacturing
quality
clinical
safety
labeling
#WHO API invitation
#active pharmaceutical ingredient
#buprenorphine hydrochloride
#methadone hydrochloride
#naloxone hydrochloride
Official Source Document Source Verified
Access the original document directly from WHO.